Page 5 of 7
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
2H), 7.70 (d, J = 7.2 Hz, 2H), 7.47-7.43 (m, 5H), 7.35 (t, J = 7.6 Hz, 1H), 2.51
Characterization Data for the Products. 2,5-Diphenyloxazole (3aa):
Purified by column chromatography (petroleum ether/ethyl acetate = 50:1), 50
mg, 76% yield, known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3)
δ: 8.13 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 7.2 Hz, 2H), 7.49-7.42 (m, 6H), 7.36 (t,
J = 7.6 Hz, 1H); 13C{H} NMR (100 MHz, CDCl3) δ: 161.0, 151.1, 130.2,
128.8, 128.7, 128.3, 127.9, 127.3, 126.1, 124.1, 123.3; IR (neat cm-1) 3063,
1602, 1566, 1485, 1129, 947; LRMS (EI 70 ev) m/z: 221 (M+); HRMS m/z
(ESI) calcd for C15H12NO (M+H)+ 222.0913, found 222.0921.
(s, 3H); 13C{H} NMR (100 MHz, CDCl3) δ: 159.2, 145.3, 133.3, 130.1, 129.0,
128.7, 128.7, 128.4, 127.5, 127.3, 126.1, 125.2, 13.4; IR (neat cm-1) 3413,
2931, 1604, 1511, 1454, 869; LRMS (EI 70 ev) m/z: 235 (M+); HRMS m/z
(ESI) calcd for C16H14NO (M+H)+ 236.1070, found 236.1081.
2-(4-Methoxyphenyl)-5-phenyloxazole (3ba): Purified by column
chromatography (petroleum ether/ethyl acetate = 30:1), 59 mg, 79% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 8.04 (d, J =
9.2 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.44-7.39 (m, 3H), 7.31 (t, J = 7.2 Hz,
1H), 6.99 (d, J = 9.2 Hz, 2H), 3.85 (s, 3H); 13C{H} NMR (100 MHz, CDCl3) δ:
161.2, 161.1, 150.6, 128.8, 128.1, 128.0, 127.8, 123.9, 123.1, 120.1, 114.1,
55.3; IR (neat cm-1) 3393, 2934, 1607, 1486, 1134, 723; LRMS (EI 70 ev) m/z:
251 (M+); HRMS m/z (ESI) calcd for C16H14NO2 (M+H)+ 252.1019, found
252.1027.
2-Phenyl-5-(p-tolyl)oxazole (3ab): Purified by column chromatography
(petroleum ether/ethyl acetate = 50:1), 54 mg, 77% yield, known compound,[4e]
white solid; 1H NMR (400 MHz, CDCl3) δ: 8.00 (d, J = 8.0 Hz, 2H), 7.52 (d, J
= 8.0 Hz, 2H), 7.39-7.34 (m, 3H), 7.29 (s, 1H), 7.15 (d, J = 9.2 Hz, 2H), 2.28
(s, 3H); 13C{H} NMR (100 MHz, CDCl3) δ: 160.7, 151.4, 138.4, 130.1, 129.5,
129.1, 128.7, 126.1, 125.2, 124.0, 122.7, 21.3; IR (neat cm-1) 3403, 2927, 1611,
1543, 1445, 1304, 953, 726; LRMS (EI 70 ev) m/z: 235 (M+); HRMS m/z (ESI)
calcd for C16H14NO (M+H)+ 236.1070, found 236.1072.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2-(4-Chlorophenyl)-5-phenyloxazole
(3ca):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 40:1), 52 mg, 68% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 8.06 (d, J =
8.8 Hz, 2H), 7.78 (d, J = 7.2 Hz, 2H), 7.48-7.44 (m, 5H), 7.39 (t, J = 7.2 Hz,
1H); 13C{H} NMR (100 MHz, CDCl3) δ: 160.2, 151.3, 136.4, 129.1, 128.8,
127.8, 127.6, 127.5, 126.9, 124.6, 123.6; IR (neat cm-1) 3429, 1602, 1554,
1433, 1341, 836; LRMS (EI 70 ev) m/z: 255 (M+); HRMS m/z (ESI) calcd for
C15H11ClNO (M+H)+ 256.0524, found 256.0532.
5-(4-Methoxyphenyl)-2-phenyloxazole
(3ac):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 30:1), 53 mg, 71% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 8.00 (d, J =
8.4 Hz, 2H), 7.54 (d, J = 8.8 Hz, 2H), 7.39-7.33 (m, 3H), 7.21 (s, 1H), 6.86 (d,
J = 8.8 Hz, 2H), 3.72 (s, 3H); 13C{H} NMR (100 MHz, CDCl3) δ: 160.4, 159.6,
151.1, 130.0, 128.6, 127.4, 126.0, 125.6, 121.8, 120.7, 114.2, 55.2; IR (neat
cm-1) 3387, 2912, 1567, 1421, 1238, 823; LRMS (EI 70 ev) m/z: 251 (M+);
HRMS m/z (ESI) calcd for C16H14NO2 (M+H)+ 252.1019, found 252.1027.
2-(4-Fluorophenyl)-5-phenyloxazole
(3da):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 40:1), 50 mg, 70% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 8.11 (dd, J =
6.8 Hz, J = 5.2 Hz, 2H), 7.71 (d, J = 7.2 Hz, 2H), 7.49-7.42 (m, 3H), 7.36 (t, J
= 7.2 Hz, 1H), 7.19 (t, J = 8.0 Hz, 2H); 13C{H} NMR (100 MHz, CDCl3) δ:
165.2 (d, J = 249.5 Hz), 160.2, 151.2, 129.0, 128.9, 128.4 (d, J = 2.2 Hz),
128.3, 128.2, 127.8, 124.1, 123.7 (d, J = 2.9 Hz), 116.0 (d, J = 22.0 Hz); IR
(neat cm-1) 3411, 3033, 1612, 1476, 1273, 903; LRMS (EI 70 ev) m/z: 239
(M+); HRMS m/z (ESI) calcd for C15H11FNO (M+H)+ 240.0819, found
240.0819.
5-(2-Bromophenyl)-2-phenyloxazole
(3ad):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 40:1), 63 mg, 70% yield,
known compound,[4e] pale yellow solid; 1H NMR (400 MHz, CDCl3) δ: 8.01-
7.99 (m, 2H), 7.84 (s, 1H), 7.72 (dd, J = 2.0 Hz, J = 1.6 Hz, 1H), 7.57 (dd, J =
0.8 Hz, J = 1.2 Hz, 1H), 7.37-7.34 (m, 3H), 7.30-7.26 (m, 1H), 7.07-7.03 (ddd,
J = 2.0 Hz, J = 1.2 Hz, J = 1.6 Hz, 1H); 13C{H} NMR (100 MHz, CDCl3) δ:
160.9, 148.6, 134.0, 130.4, 129.1, 128.7, 128.6, 128.3, 128.0, 127.4, 127.0,
126.3, 119.7; LRMS (EI 70 ev) m/z: 299 (M+); HRMS m/z (ESI) calcd for
C15H11BrNO (M+H)+ 300.0019, found 300.0034.
5-Phenyl-2-(thiophen-2-yl)oxazole
(3ea):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 50:1), 50 mg, 73% yield,
known compound,[4e] light yellow solid; 1H NMR (400 MHz, CDCl3) δ: 7.74
(d, J = 4.0 Hz, 1H), 7.70 (d, J = 7.2 Hz, 2H), 7.45-7.43 (m, 3H), 7.39 (s, 1H),
7.35 (t, J = 7.6 Hz, 1H), 7.14 (t, J = 7.2 Hz, 1H); 13C{H} NMR (100 MHz,
CDCl3) δ: 157.3, 150.7, 129.9, 128.8, 128.4, 128.2, 127.9, 127.6, 127.5, 124.0,
123.2; IR (neat cm-1) 3403, 3021, 1601, 1424, 1203, 876; LRMS (EI 70 ev)
m/z: 227 (M+); HRMS m/z (ESI) calcd for C13H10NOS (M+H)+ 228.0478,
found 228.0483.
5-Phenyl-2-(4-fluoro-3-chlorophenyl)oxazole (3fa): Purified by column
chromatography (petroleum ether/ethyl acetate = 30:1), 49 mg, 60% yield, new
compound, white solid; 1H NMR (400 MHz, CDCl3) δ: 7.89 (d, J = 8.0 Hz,
1H), 7.90-7.87 (dt, J = 2.4 Hz, J = 1.6 Hz, 1H), 7.62 (d, J = 7.2 Hz, 2H), 7.45-
7.40 (m, 3H), 7.36 (t, J = 7.6 Hz, 1H), 7.16 (td, J = 2.4 Hz, J = 2.4 Hz, J = 2.4
Hz, 1H); 13C{H} NMR (100 MHz, CDCl3) δ: 164.0, 161.6, 159.83, 159.80,
151.5, 130.48, 130.40, 129.3, 129.2, 128.8, 128.5, 127.6, 124.1, 123.4, 121.88,
121.85, 117.2, 117.0, 113.2, 112.9; IR (neat cm-1) 3411, 1575, 1412, 1128, 916,
709; LRMS (EI 70 ev) m/z: 273 (M+); HRMS m/z (ESI) calcd for
C15H10ClFNO (M+H)+ 274.0429, found 274.0439.
5-Phenyl-2-propyloxazole (3ga): Purified by column chromatography
(petroleum ether/ethyl acetate = 40:1), 27 mg, 49% yield, known compound,[4e]
yellow oil; 1H NMR (500 MHz, CDCl3) δ: 7.65 (d, J = 7.5 Hz, 2H), 7.44 (t, J =
7.5 Hz, 2H), 7.34 (t, J = 7.5 Hz, 1H), 7.30 (s, 1H), 2.84 (t, J = 7.5 Hz, 2H), 1.89
(m, 2H), 1.06 (t, J = 7.5 Hz, 3H); 13C{H} NMR (100 MHz, CDCl3) δ: 164.5,
150.8, 128.8, 128.2, 128.0, 123.9, 121.6, 30.1, 21.5, 13.6; IR (neat cm-1) 3455,
2927, 1559, 1451, 1239, 774; LRMS (EI 70 ev) m/z: 187 (M+); HRMS m/z
(ESI) calcd for C12H14NO (M+H)+ 188.1070, found 188.1061.
5-(4-Fluorophenyl)-2-phenyloxazole
(3ae):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 40:1), 38 mg, 53% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 7.98 (dd, 1J =
2.4 Hz, 2J = 1.6 Hz, 2H), 7.58 (dd, 1J = 5.2 Hz, 2J = 5.2 Hz, 2H), 7.37-7.33 (m,
3H), 7.26 (s, 1H), 7.03 (t, J = 8.8 Hz, 2H); 13C{H} NMR (100 MHz, CDCl3) δ:
163.8 (d, J = 225.1 Hz), 161.0, 150.3, 130.3, 128.7, 127.2, 126.1 (d, J = 15.3
Hz), 124.3, 124.2, 123.0 (d, J = 1.2 Hz), 116.1 (d, J = 22.0 Hz); IR (neat cm-1)
3433, 1619, 1449, 1127, 813; LRMS (EI 70 ev) m/z: 239 (M+); HRMS m/z
(ESI) calcd for C15H11FNO (M+H)+ 240.0819, found 240.0829.
4-(2-Phenyloxazol-5-yl)benzonitrile
(3af):
Purified
by
column
chromatography (petroleum ether/ethyl acetate = 30:1), 49 mg, 66% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 8.12 (dd, J =
3.6 Hz, J = 2.8 Hz, 2H), 7.81 (d, J = 8.4 Hz, 2H), 7.73 (d, J = 8.4 Hz, 2H), 7.58
(s, 1H), 7.49 (t, J = 3.6 Hz, 3H); 13C{H} NMR (100 MHz, CDCl3) δ: 162.3,
149.2, 132.7, 131.8, 130.9, 128.8, 126.7, 126.4, 126.2, 124.2, 118.5, 111.4; IR
(neat cm-1) 3380, 2221, 1601, 1414, 910; LRMS (EI 70 ev) m/z: 246 (M+);
HRMS m/z (ESI) calcd for C16H11N2O (M+H)+ 247.0866, found 247.0877.
5-(3,4-Dimethoxyphenyl)-2-phenyloxazole (3ag): Purified by column
chromatography (petroleum ether/ethyl acetate = 20:1), 58 mg, 69% yield,
known compound,[4e] white solid; 1H NMR (400 MHz, CDCl3) δ: 8.10 (d, J =
8.0 Hz, 2H), 7.50-7.44 (m, 3H), 7.33-7.19 (m, 2H), 7.18 (s, 1H), 6.93 (d, J =
8.4 Hz, 1H), 3.97 (s, 3H), 3.92 (s, 3H); 13C{H} NMR (100 MHz, CDCl3) δ:
160.5, 151.2, 149.3, 149.2, 130.1, 128.7, 127.4, 126.0, 122.1, 120.9, 117.1,
111.3, 107.2, 55.95, 55.91; IR (neat cm-1) 3423, 2931, 1606, 1448, 1119, 937,
705; LRMS (EI 70 ev) m/z: 281 (M+); HRMS m/z (ESI) calcd for C17H16NO3
(M+H)+ 282.1125, found 282.1117.
5-(5-Bromothiophen-2-yl)-2-phenyloxazole (3ah): Purified by column
chromatography (petroleum ether/ethyl acetate = 50:1), 58 mg, 64% yield, new
compound, yellow solid; 1H NMR (400 MHz, CDCl3) δ: 7.98 (dd, J = 4.4 Hz, J
= 2.4 Hz, 2H), 7.39 (dd, J = 1.2 Hz, J = 2.0 Hz, 3H), 7.17 (s, 1H), 7.01 (d, J =
3.6 Hz, 1H), 6.96 (d, J = 3.6 Hz, 1H); 13C{H} NMR (100 MHz, CDCl3) δ:
159.7, 144.5, 129.6, 129.5, 127.8, 126.8, 125.8, 125.2, 123.2, 122.3, 111.7; IR
(neat cm-1) 3369, 1620, 1469, 1340, 729; LRMS (EI 70 ev) m/z: 306 (M+);
HRMS m/z (ESI) calcd for C13H9BrNOS (M+H)+ 305.9583, found 305.9594.
(E)-2-Phenyl-5-styryloxazole (3ai): Purified by column chromatography
(petroleum ether/ethyl acetate = 50:1), 38 mg, 51% yield, known compound,[4e]
white solid; 1H NMR (400 MHz, CDCl3) δ: 8.12 (d, J = 8.0 Hz, 2H), 7.52-7.46
(m, 5H), 7.40 (t, J = 7.2 Hz, 2H), 7.31 (t, J = 7.6 Hz, 1H), 7.16 (t, J = 6.8 Hz,
2H), 6.96 (d, J = 16.4 Hz, 1H); 13C{H} NMR (100 MHz, CDCl3) δ: 161.0,
150.3, 136.3, 130.4, 129.4, 128.7, 128.2, 127.2, 126.5, 126.4, 126.3, 113.0; IR
(neat cm-1) 3393, 1603, 1463, 1336, 1139, 710; LRMS (EI 70 ev) m/z: 247
(M+); HRMS m/z (ESI) calcd for C17H14NO (M+H)+ 248.1070, found 248.1074.
4-Methyl-2,5-diphenyloxazole (3ak): Purified by column chromatography
(petroleum ether/ethyl acetate = 50:1), 53 mg, 75% yield, known compound,[4e]
white solid; 1H NMR (400 MHz, CDCl3) δ: 8.10 (dd, J = 2.0 Hz, J = 1.6 Hz,
5-Phenyl-2-vinyloxazole (3ha): Purified by column chromatography
(petroleum ether/ethyl acetate = 30:1), 23 mg, 44% yield, known compound,[4e]
1
yellow oil; H NMR (500 MHz, CDCl3) δ: 7.67 (d, J = 7.2 Hz, 2H), 7.44-7.40
(m, 2H), 7.36 (s, 1H), 7.35 (t, J = 7.6 Hz, 1H), 6.67 (dd, J = 11.2 Hz, J = 11.2
Hz, 1H), 6.27 (dd, J = 1.2 Hz, J = 0.8 Hz, 1H), 5.67 (dd, J = 0.8 Hz, J = 0.8 Hz,
1H); 13C{H} NMR (100 MHz, CDCl3) δ: 160.4, 150.8, 131.2, 128.8, 128.5,
127.7, 124.1, 123.3, 121.5; IR (neat cm-1) 3093, 1631, 1557, 1443, 992, 761;
LRMS (EI 70 ev) m/z: 171 (M+); HRMS m/z (ESI) calcd for C11H10NO
(M+H)+ 172.0757, found 172.0747.
2-Ethynyl-5-phenyloxazole (3ia): Purified by column chromatography
(petroleum ether/ethyl acetate = 30:1), 28 mg, 56% yield, new compound,
yellow solid; 1H NMR (400 MHz, CDCl3) δ: 7.58 (d, J = 7.2 Hz, 2H), 7.36 (t, J
= 8.0 Hz, 2H), 7.29-7.25 (m, 1H), 7.17 (s, 1H), 3.24 (s, 1H); 13C{H} NMR
(100 MHz, CDCl3) δ: 156.9, 152.3, 129.1, 128.9, 128.4, 125.3, 122.8, 80.4,
71.5; IR (neat cm-1) 3312, 2209, 1571, 1422, 1129, 720; LRMS (EI 70 ev) m/z:
169 (M+); HRMS m/z (ESI) calcd for C11H8NO (M+H)+ 170.0600, found
170.0593.
ASSOCIATED CONTENT
ACS Paragon Plus Environment